{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Antiviral",
      "COVID-19",
      "Coronavirus",
      "Repurposed drugs",
      "SARS-CoV-2"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "32992245",
  "DateCompleted": {
    "Year": "2020",
    "Month": "12",
    "Day": "21"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "12"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2020",
        "Month": "09",
        "Day": "10"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.bmc.2020.115757",
      "S0968-0896(20)30587-3"
    ],
    "Journal": {
      "ISSN": "1464-3391",
      "JournalIssue": {
        "Volume": "28",
        "Issue": "23",
        "PubDate": {
          "Year": "2020",
          "Month": "Dec",
          "Day": "01"
        }
      },
      "Title": "Bioorganic & medicinal chemistry",
      "ISOAbbreviation": "Bioorg Med Chem"
    },
    "ArticleTitle": "COVID-19 therapy: What weapons do we bring into battle?",
    "Pagination": {
      "StartPage": "115757",
      "MedlinePgn": "115757"
    },
    "Abstract": {
      "AbstractText": [
        "Urgent treatments, in any modality, to fight SARS-CoV-2 infections are desired by society in general, by health professionals, by Estate-leaders and, mainly, by the scientific community, because one thing is certain amidst the numerous uncertainties regarding COVID-19: knowledge is the means to discover or to produce an effective treatment against this global disease. Scientists from several areas in the world are still committed to this mission, as shown by the accelerated scientific production in the first half of 2020 with over 25,000 published articles related to the new coronavirus. Three great lines of publications related to COVID-19 were identified for building this article: The first refers to knowledge production concerning the virus and pathophysiology of COVID-19; the second regards efforts to produce vaccines against SARS-CoV-2 at a speed without precedent in the history of science; the third comprehends the attempts to find a marketed drug that can be used to treat COVID-19 by drug repurposing. In this review, the drugs that have been repurposed so far are grouped according to their chemical class. Their structures will be presented to provide better understanding of their structural similarities and possible correlations with mechanisms of actions. This can help identifying anti-SARS-CoV-2 promising therapeutic agents."
      ],
      "CopyrightInformation": "Copyright \u00a9 2020 Elsevier Ltd. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laborat\u00f3rio de Biologia Molecular, Universidade de Pernambuco, Garanhuns, PE, Brazil; Laborat\u00f3rio de Qu\u00edmica e Inova\u00e7\u00e3o Terap\u00eautica (LQIT) - Departamento de Antibi\u00f3ticos, Universidade Federal de Pernambuco, Recife, PE, Brazil; Laborat\u00f3rio de Imunopatologia Keizo Asami (LIKA), Universidade Federal de Pernambuco, Recife, PE, Brazil. Electronic address: sinara.monica@upe.br."
          }
        ],
        "LastName": "de Almeida",
        "ForeName": "Sinara M\u00f4nica Vitalino",
        "Initials": "SMV"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laborat\u00f3rio de Qu\u00edmica e Inova\u00e7\u00e3o Terap\u00eautica (LQIT) - Departamento de Antibi\u00f3ticos, Universidade Federal de Pernambuco, Recife, PE, Brazil."
          }
        ],
        "LastName": "Santos Soares",
        "ForeName": "Jos\u00e9 Cleberson",
        "Initials": "JC"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laborat\u00f3rio de Qu\u00edmica e Inova\u00e7\u00e3o Terap\u00eautica (LQIT) - Departamento de Antibi\u00f3ticos, Universidade Federal de Pernambuco, Recife, PE, Brazil."
          }
        ],
        "LastName": "Dos Santos",
        "ForeName": "Keriolaine Lima",
        "Initials": "KL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laborat\u00f3rio de Imunopatologia Keizo Asami (LIKA), Universidade Federal de Pernambuco, Recife, PE, Brazil."
          }
        ],
        "LastName": "Alves",
        "ForeName": "Josival Emanuel Ferreira",
        "Initials": "JEF"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laborat\u00f3rio de Qu\u00edmica e Inova\u00e7\u00e3o Terap\u00eautica (LQIT) - Departamento de Antibi\u00f3ticos, Universidade Federal de Pernambuco, Recife, PE, Brazil."
          }
        ],
        "LastName": "Ribeiro",
        "ForeName": "Am\u00e9lia Galdino",
        "Initials": "AG"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laborat\u00f3rio de Qu\u00edmica e Inova\u00e7\u00e3o Terap\u00eautica (LQIT) - Departamento de Antibi\u00f3ticos, Universidade Federal de Pernambuco, Recife, PE, Brazil."
          }
        ],
        "LastName": "Jacob",
        "ForeName": "\u00cdris Trindade Ten\u00f3rio",
        "Initials": "\u00cdTT"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laborat\u00f3rio de Biologia Molecular, Universidade de Pernambuco, Garanhuns, PE, Brazil."
          }
        ],
        "LastName": "da Silva Ferreira",
        "ForeName": "Cindy Juliane",
        "Initials": "CJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laborat\u00f3rio de Biologia Molecular, Universidade de Pernambuco, Garanhuns, PE, Brazil."
          }
        ],
        "LastName": "Dos Santos",
        "ForeName": "J\u00e9ssica Celerino",
        "Initials": "JC"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laborat\u00f3rio de Qu\u00edmica e Inova\u00e7\u00e3o Terap\u00eautica (LQIT) - Departamento de Antibi\u00f3ticos, Universidade Federal de Pernambuco, Recife, PE, Brazil."
          }
        ],
        "LastName": "de Oliveira",
        "ForeName": "Jamerson Ferreira",
        "Initials": "JF"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laborat\u00f3rio de Imunopatologia Keizo Asami (LIKA), Universidade Federal de Pernambuco, Recife, PE, Brazil."
          }
        ],
        "LastName": "de Carvalho Junior",
        "ForeName": "Luiz Bezerra",
        "Initials": "LB"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laborat\u00f3rio de Qu\u00edmica e Inova\u00e7\u00e3o Terap\u00eautica (LQIT) - Departamento de Antibi\u00f3ticos, Universidade Federal de Pernambuco, Recife, PE, Brazil."
          }
        ],
        "LastName": "de Lima",
        "ForeName": "Maria do Carmo Alves",
        "Initials": "MDCA"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Bioorg Med Chem",
    "NlmUniqueID": "9413298",
    "ISSNLinking": "0968-0896"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "COVID-19 Vaccines"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "chemistry",
        "therapeutic use"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [
        "immunology",
        "therapy"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "COVID-19 Vaccines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Repositioning"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "drug effects",
        "immunology"
      ],
      "DescriptorName": "SARS-CoV-2"
    }
  ],
  "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."
}